All Stories

  1. Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts
  2. Response by Eichelmann and Schulze to Letter Regarding Article, “Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation”
  3. Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort
  4. Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
  5. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition
  6. Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer
  7. Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation
  8. Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors
  9. Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
  10. Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort
  11. The impact of dietary saturated fat replacement with unsaturated fat on the plasma lipidome and cardiometabolic disease risk
  12. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort
  13. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study
  14. 357-P: Advanced Glycation End Products Associate with Vascular Stiffness in Diabetic, Prediabetic, and Normoglycemic Individuals
  15. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
  16. Lipid Profiles and Heart Failure Risk
  17. Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
  18. Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes
  19. Reproducibility of Novel Immune-Inflammatory Biomarkers Over 4 Months: An Analysis with Repeated Measures Design
  20. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer
  21. Chemerin as a Biomarker Linking Inflammation and Cardiovascular Diseases
  22. Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS)
  23. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study
  24. Reply to JJ Meerpohl et al.
  25. Association Between Peripheral Adipokines and Inflammation Markers: A Systematic Review and Meta-Analysis
  26. Methodological utility of chemerin as a novel biomarker of immunity and metabolism
  27. Novel adipokines: methodological utility in human obesity research
  28. Perspective: NutriGrade: A Scoring System to Assess and Judge the Meta-Evidence of Randomized Controlled Trials and Cohort Studies in Nutrition Research
  29. Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity
  30. Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials
  31. Role of genetic variants in ADIPOQ in human eating behavior